The Use of Organoid Models of Endocrine Diseases: Research Progress and Potential
Oncology Communications · 06.02.2026 · 1 (1) · 8-19
DOI: 10.62762/oc.2025.777438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Communications, online erschienen am 06.02.2026. Verfasst von Jiayu Liu und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The absence of robust and reliable $in \, vitro$ models that can accurately recapitulate the biological characteristics of many mammalian tissues and disease states represents a major barrier to both basic and translational research, owing to limited sample availability and ethical concerns. Stem cell-derived self-assembling three-dimensional (3D) organoids can replicate key structural and functional aspects of organs in a more physiologically relevant manner than traditional 2D models, thus providing a superior platform for simulating human physiology and pathology. To date, researchers have developed organoid models for a variety of endocrine tissues and their associated diseases (including pancreatic, pituitary, thyroid, adrenal tumors, etc.), offering invaluable tools for studying complex endocrine disorders. Such organoid models have significantly enhanced the accuracy and translational potential of research in disease modeling, drug screening, and regenerative medicine. Looking forward, the integration of bioengineering and multi-omics analyses with next-generation organoid models holds great promise for unraveling disease mechanisms and advancing precision medicine.
Zitieren
APA
Liu, J., & Li, P. (2026). The Use of Organoid Models of Endocrine Diseases: Research Progress and Potential. Oncology Communications, 1(1), 8-19. https://doi.org/10.62762/oc.2025.777438
Vancouver
Liu J, Li P. The Use of Organoid Models of Endocrine Diseases: Research Progress and Potential. Oncology Communications. 2026;1(1):8-19. doi:10.62762/oc.2025.777438
BibTeX
@article{Liu2026,
author = {Liu, Jiayu and Li, Peiting},
title = {The Use of Organoid Models of Endocrine Diseases: Research Progress and Potential},
journal = {Oncology Communications},
year = {2026},
volume = {1},
number = {1},
pages = {8--19},
doi = {10.62762/oc.2025.777438}
}
EUVIMED